11 August 2025
Half year results for the six months ended 30 June 2025 ‘Transform & Grow’ strategy delivers a return to Group revenue growth in subdued…
Gepotidacin accepted for priority review by the US FDA for the oral treatment of uncomplicated urogenital gonorrhoea GSK plc (LSE/NYSE: GSK) today announced that…
7 August 2025
RESULT OF SECONDARY PLACING OF 3,626,440 ORDINARY SHARES IN B.P. MARSH & PARTNERS PLC Further to the announcement made yesterday, PSC UK Pty Ltd…
B.P. Marsh & Partners Plc (“B.P. Marsh” or the “Company”) Transaction in Own Shares and Total Voting Rights Further to the Company’s announcement yesterday,…
5 August 2025
Preliminary results Year ended 30 June 2025 Reported results Adjusted results(1) F25 vs F24 F25 vs F24 Net sales $20,245m (0.1)%…
GlobalData Plc (AIM: DATA, GlobalData, the Group) Proposed return of capital of up to £60 million by way of a purchase of up to…
GlobalData Plc Half Year Results 30 June 2025 Resilient H1 performance and good progress in Growth Transformation Plan GlobalData Plc (AIM: DATA, GlobalData, the…
1 August 2025
Euronext’s diversified business drives all-time record results, supported by organic growth, favourable market conditions and disciplined capital allocation. Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo…